N. Renwick et al., Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma, AIDS, 12(18), 1998, pp. 2481-2488
Background: The finding of antibodies against human herpesvirus 8 (HHV-8) i
s associated with the occurrence of Kaposi's sarcoma in persons infected wi
th HIV. However, the predictive Value of HHV-8 antibodies for Kaposi's sarc
oma in HIV infection is unknown.
Methods: The Amsterdam Cohort Studies on HIV infection and AIDS started in
1984 for homosexual men and in 1985 for injecting drug users. Serum samples
from 1459 homosexual men and 1167 drug users were tested for antibodies to
recombinant HHV-8 lytic-phase capsid (ORF65) antigen and latent-phase nucl
ear (ORF73) antigen. Individuals were retrospectively identified as HHV-8-p
ositive oi HHV-8-negative at enrolment or HHV-8 seroconverter during the st
udy. Kaposi's sarcoma-free survival time was compared between HIV-infected
men who were positive for HHV-8 at enrolment and those who later seroconver
ted for HHV-8. Hazard ratios were estimated for Kaposi's sat-coma, lymphoma
, and opportunistic infection according to the HHV-8 serostatus.
Results: The incidence of HHV-8 seroconversion among drugs users was 0.7 pe
r 100 person-years based on 31 seroconversions, whereas an incidence of 3.6
was found among homosexual men based on 215 seroconversions. The hazard ra
tio for Kaposi's sarcoma was 3.15 (95% CI: 1.89-5.25) in HIV-infected indiv
iduals if HHV-8 antibodies were present either at enrolment or at HIV seroc
onversion. In HIV-infected persons who later seroconverted to HHV-8, Kaposi
's sarcoma developed more rapidly: hazard ratio of 5.04 (95% CI: 2.94-8.64)
, an additional risk of 1.60 (95% CI: 1.01-2.53; P = 0.04). Time-dependent
adjustment for CD4(+) cell count and HIV RNA had no impact on the additiona
l risk, although the CD4(+) cell count was an independent risk factor for K
aposi's sarcoma. HHV-8 infection did not increase the risk of AIDS-related
lymphoma or opportunistic infections.
Conclusions: The incidence of HHV-8 infection is higher in homosexual men t
han in drug users. The presence of HHV-8 antibodies in HIV-infected persons
increases the risk of Kaposi's sarcoma. Among HIV-infected persons, those
who subsequently seroconvert for HHV-8 are at highest risk. These results s
trongly confirm the causal role of HHV-8 in Kaposi's sarcoma and emphasize
the clinical relevance of HHV-8 seroconversion before and after the HIV inf
ection. (C) 1998 Lippincott Williams & Wilkins.